Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
Background Epidemiological studies have reported conflicting findings on the potential
adverse effects of long-term antihypertensive medication use on cancer risk. Naturally …
adverse effects of long-term antihypertensive medication use on cancer risk. Naturally …
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
Aims/hypothesis Epidemiological studies have generated conflicting findings on the
relationship between glucose-lowering medication use and cancer risk. Naturally occurring …
relationship between glucose-lowering medication use and cancer risk. Naturally occurring …
The evolution of mendelian randomization for investigating drug effects
Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky
and colleagues investigating the associations between genetically-proxied inhibition of …
and colleagues investigating the associations between genetically-proxied inhibition of …
Searching for cancer-associated gene polymorphisms: promises and obstacles
EN Imyanitov, AV Togo, KP Hanson - Cancer letters, 2004 - Elsevier
Low-penetrance genetic variations appear to form the most essential component of the
heritability of cancer risk. Search for relevant polymorphic candidates faces significant …
heritability of cancer risk. Search for relevant polymorphic candidates faces significant …
Association of hypertension drug target genes with blood pressure and hypertension in 86 588 individuals
AD Johnson, C Newton-Cheh, DI Chasman… - …, 2011 - Am Heart Assoc
We previously conducted genome-wide association meta-analysis of systolic blood
pressure, diastolic blood pressure, and hypertension in 29 136 people from 6 cohort studies …
pressure, diastolic blood pressure, and hypertension in 29 136 people from 6 cohort studies …
A compendium of genome-wide associations for cancer: critical synopsis and reappraisal
JPA Ioannidis, P Castaldi… - JNCI: Journal of the …, 2010 - academic.oup.com
Abstract Since 2007, genome-wide association (GWA) studies have identified numerous
well-supported, novel genetic risk loci for common cancers; however, there are concerns …
well-supported, novel genetic risk loci for common cancers; however, there are concerns …
Quantifying the genetic correlation between multiple cancer types
Background: Many cancers share specific genetic risk factors, including both rare high-
penetrance mutations and common SNPs identified through genome-wide association …
penetrance mutations and common SNPs identified through genome-wide association …
Genome-wide association studies: how predictable is a person's cancer risk?
DH Roukos - Expert review of anticancer therapy, 2009 - Taylor & Francis
From overenthusiasm to scientific assessment and hard reality, the time required for this
transiton has recently been drastically shortened. As high-throughput screening technology …
transiton has recently been drastically shortened. As high-throughput screening technology …
Genome-wide association studies in cancer—current and future directions
CC Chung, WCS Magalhaes… - …, 2010 - academic.oup.com
Genome-wide association studies (GWAS) have emerged as an important tool for
discovering regions of the genome that harbor genetic variants that confer risk for different …
discovering regions of the genome that harbor genetic variants that confer risk for different …
Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review
L Jing, L Su, BZ Ring - PloS one, 2014 - journals.plos.org
The clinical use of genetic variation in the evaluation of cancer risk is expanding, and thus
understanding how determinants of cancer susceptibility identified in one population can be …
understanding how determinants of cancer susceptibility identified in one population can be …
相关搜索
- common cancers therapeutic inhibition
- randomization analysis therapeutic inhibition
- common cancers randomization analysis
- drug targets therapeutic inhibition
- common cancers drug targets
- drug targets randomization analysis
- mendelian randomization drug effects
- genetic variation cancer risk
- risk of cancer randomisation analysis
- genetic correlation cancer types
- ethnic background cancer risk